Oyster has a unique approach to fundraising across the life sciences and healthcare sectors
By combining significant sector expertise with investment transaction experience, Oyster’s long-standing experience has enabled us to reimagine the optimum approaches to raising earlier stage high risk investment more quickly and more cost effectively
Who We Are
Oyster Venture Partners consists of a multi-disciplinary team of highly experienced operational deal makers who have worked across the biotechnology, therapeutic, diagnostic, medical technology, digital healthcare and healthcare
sectors around the globe. Our culture centres on closely partnering our client base, throughout the capital raising process supporting all levels of experienced leaders with a wide range of funding and corporate transactions.
Meet the team
Management Team
David D’Alton
Executive Chairman
40 years’ international business development experience in corporate information technology (IBM and Digital Equipment Corp), and Life Sciences innovation. Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.
Rupert Lewis
CEO
25+ years’ international corporate transaction experience, with a driving passion for supporting innovation in healthcare. Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.
Sarah Taylor, MA, FCIPD
Chief People Officer
International Board level experience in FTSE companies, Investment Banking & Private Equity gained in Professional Services, Life Sciences and the TIC (Testing, Inspection & Certification) sectors. Leading Oyster’s commercial and scientific Advisory Boards development strategies.
Venture Partner Team
Dr Kris Motmans, PhD
Venture Partner and Chief Scientific Investment Officer
Serial advisor within the life science sector, covering both public and private transactions, covering investment sourcing and completion.
Carl Weir, B.Commm
Venture Partner and CDO – Digital Health and Data Valuation
Serial digital transformation/product strategy innovator in finance, legal, AI, ML, Big Data, blockchain, payments, digital healthcare and data valuation. Significant investment banking background – HSBC, ABN AMRO, Credit Suisse, Barclays, Westpac, Wall Street Systems
Aswad Martin
Chief Mathematician
An accomplished Data Scientist with a background in statistical analysis including hypothesis testing, data manipulation and exploratory data analysis, backed by object-oriented programming, now a key contributor to Oyster’s new growing Data Valuation business.
Analyst Team
Kaarel Aulik
Senior Analyst
10+ years experience within the healthcare sector, supporting strategic decision making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.
Business Engagement Team
Benny Daniëls, MSc
Business Engagement & Scientific Advisory Lead
40 years’ corporate / SME business development and consulting experience in US, Scandinavia, Baltics, UK and India. Strong biopharmaceutical industry history (GSK Biologics, Johnson & Johnson) in immuno-biologicals, personalised medicines and small molecules.